28.23
Mineralys Therapeutics Inc Aktie (MLYS) Neueste Nachrichten
Profit Recap: Is Mineralys Therapeutics Inc impacted by rising ratesQuarterly Growth Report & Low Drawdown Trading Techniques - baoquankhu1.vn
Why Mineralys Therapeutics Stock Is Surging Today - TipRanks
Avalyn Appoints Biopharmaceutical Veteran to Board - National Today
Avalyn Appoints Jon Congleton To Board - citybiz
Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors - The Manila Times
Mineralys Therapeutics (MLYS) garnering attention with lorundrostat progress - MSN
Earnings Miss: Whats the RSI of Mineralys Therapeutics Inc stock2026 Levels & Capital Protection Trading Alerts - baoquankhu1.vn
Mineralys Therapeutics CEO Congleton sells $1.97 million in MLYS stock By Investing.com - Investing.com Australia
Insider Sell: CEO Jon Congleton Sells 75,000 Shares of Mineralys Therapeutics Inc (MLYS) - GuruFocus
Mineralys Therapeutics (NASDAQ:MLYS) CEO Jon Congleton Sells 75,000 Shares - MarketBeat
Insider Selling: Mineralys Therapeutics (NASDAQ:MLYS) Director Sells 3,000 Shares of Stock - MarketBeat
Daphne Karydas, director at Mineralys, sells $75,000 in MLYS stock By Investing.com - Investing.com Australia
Daphne Karydas, director at Mineralys, sells $75,000 in MLYS stock - Investing.com
Mineralys Therapeutics CEO Congleton sells $1.97 million in MLYS stock - Investing.com
Mineralys (MLYS) CEO sells 75,000 shares, still holds 705k - Stock Titan
Mineralys Therapeutics (MLYS) director trades 3,000 shares under plan - Stock Titan
IPO Launch: How sensitive is Mineralys Therapeutics Inc to inflationMarket Rally & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Mineralys Therapeutics (NASDAQ:MLYS) Director Acquires $7,354,269.00 in Stock - MarketBeat
Mineralys Therapeutics, Inc. (MLYS) stock price, news, quote and history - Yahoo Finance UK
Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), Neumora Therapeutics, Inc. (NMRA) and Gain Therapeutics (GANX) - The Globe and Mail
Mineralys Therapeutics Surges on FDA Milestone Buzz - TipRanks
Mineralys Therapeutics (MLYS) Garnering Attention With Lorundrostat Progress - Insider Monkey
Mineralys Therapeutics(MLYS.US) Director Buys US$8.76 Million in Common Stock - 富途牛牛
Mineralys Therapeutics (NASDAQ: MLYS) insider sells 3,000 shares - Stock Titan
Mineralys Therapeutics (MLYS) files Form 144 to sell 75,000 shares - Stock Titan
RA Capital funds add 369,000 Mineralys (NASDAQ: MLYS) shares - Stock Titan
Mineralys Therapeutics (NASDAQ:MLYS) Stock Price Up 12.4%What's Next? - MarketBeat
Investors Purchase High Volume of Mineralys Therapeutics Put Options (NASDAQ:MLYS) - MarketBeat
Immunic appoints biopharmaceutical executive Jon Congleton to board - Yahoo! Finance Canada
Ex-Copaxone launch executive joins Immunic board as MS trial nears - stocktitan.net
(MLYS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
SG Americas Securities LLC Buys 130,758 Shares of Mineralys Therapeutics, Inc. $MLYS - MarketBeat
Major Insider Power Move Signals Growing Confidence in Mineralys Therapeutics - TipRanks
Mineralys Therapeutics, Inc.Common Stock (NQ: MLYS - FinancialContent
Mineralys reports 2025 results, advances hypertension drug review - MSN
Mineralys Therapeutics names Jeffrey Munsie as chief legal officer By Investing.com - Investing.com Australia
Biopharma Co. Gives New CLO $3.6 Million In Stock Awards - Law360
Mineralys Therapeutics grants inducement equity awards to two new employees - msn.com
Mineralys Therapeutics appoints Jeffrey Munsie as chief legal officer - TipRanks
Mineralys Grants Inducement Equity Awards to New Employee - MyChesCo
Mineralys Therapeutics Appoints Jeffrey A. Munsie as Chief Legal Officer - citybiz
Mineralys Therapeutics names Jeffrey Munsie as chief legal officer - Investing.com
Mineralys Therapeutics appoints Jeffrey A. Munsie as chief legal officer - MarketScreener
Mineralys Therapeutics Appoints Jeffrey A. Munsie As Chief Legal Officer - TradingView
Mineralys Therapeutics (MLYS) Is Down 8.1% After Narrowed Loss, FDA Lorundrostat NDA AcceptanceWhat's Changed - simplywall.st
Hudson Bay Capital Management LP Invests $2.87 Million in Mineralys Therapeutics, Inc. $MLYS - MarketBeat
Earnings Beat: Whats the profit margin of Mineralys Therapeutics IncQuarterly Risk Review & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Growth Value: What is the implied volatility of Mineralys Therapeutics Inc2026 Major Catalysts & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Is It Time To Reassess Mineralys Therapeutics (MLYS) After The Recent Share Price Pullback? - Yahoo Finance
Mineralys (MLYS) Q4 2025 Earnings Call Transcript - AOL.com
Why Mineralys Therapeutics Shares Are Sliding Today - TipRanks
Research Analysts Issue Forecasts for MLYS Q1 Earnings - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):